Organization · Venture Capital
Novatio Ventures
Novatio Ventures is a Toronto-based venture firm focused on the commercialization of early-stage life science innovations. It targets opportunities in Canada, the U.S., China, and South Korea, providing seed funding and management support to help bring technologies to market.
Overview
What Novatio Ventures does
What Novatio Ventures is
Novatio Ventures is a Toronto-based venture firm focused on the commercialization of early-stage life science innovations. It targets opportunities in Canada, the U.S., China, and South Korea, providing seed funding and management support to help bring technologies to market.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Novatio Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Novatio Ventures as a funder
Investment thesis
Novatio Ventures focuses on identifying early life-science innovations that can transform disease diagnosis and treatment, helping to move them from lab-stage or preclinical concepts toward commercialization.
Focus narrative
The firm invests in early-stage life science innovations, particularly those emerging from Canada, the U.S., China, South Korea, and other markets. Novatio Ventures leverages its global industry network and collective experience to achieve early exits that generate financial returns while mitigating risks.
Value beyond capital
Novatio Ventures adds value to its portfolio companies by providing not just capital but also management services, entity formation, interim management, fundraising strategy, licensing, partnership, and monetization support.
Focus and fit
- Stages
- Seed · Friends and Family · Accelerator
- Sectors
- Biotech · Healthcare · Diagnostics · Medical Devices · Proteomics
- Regions
- North AmericaAsia
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include: 3io Therapeutics: Focused on therapeutic innovations in the life sciences sector. Precision Proteomics: Engaged in proteomics research and development. Immvue Therapeutics: An immuno-oncology company co-founded by team member Sandy Der. Winterlight Labs: A speech-based digital biomarker platform for detecting and monitoring cognitive impairment.
Common questions
What to know about Novatio Ventures
Upseed classifies Novatio Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.